doi: 10.1007/978-1-60761-609-2_19.
LHRH-targeted nanoparticles for cancer therapeutics
Affiliations
- PMID: 20217603
- DOI: 10.1007/978-1-60761-609-2_19
Item in Clipboard
LHRH-targeted nanoparticles for cancer therapeutics
Methods Mol Biol.
2010.
Abstract
Synthesis and evaluation of a novel cancer cell's receptor-targeted internally quaternized and surface neutral poly(amidoamine) (PAMAM) generation four dendrimer as well as PAMAM-paclitaxel conjugate are described. The advantages of developed nanocarriers include but are not limited to (1) internal cationic charges for the complexation with small interfering RNA or antisense oligonucleotides and their protection from the degradation in systemic circulation; (2) neutral-modified surface for low cytotoxicity of empty unloaded dendrimers; (3) efficient internalization by cancer cells; and (4) preferential accumulation in the tumor and the prevention of adverse side effects of chemotherapy.
Similar articles
-
Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery.Bioconjug Chem. 2008 Jul;19(7):1396-403. doi: 10.1021/bc8000722. Epub 2008 Jun 25. Bioconjug Chem. 2008. PMID: 18576676
-
Colloidal gold: a novel nanoparticle for targeted cancer therapeutics.Methods Mol Biol. 2010;624:375-84. doi: 10.1007/978-1-60761-609-2_25. Methods Mol Biol. 2010. PMID: 20217609 Review.
-
Polymeric nanoparticles for drug delivery.Methods Mol Biol. 2010;624:163-75. doi: 10.1007/978-1-60761-609-2_11. Methods Mol Biol. 2010. PMID: 20217595
-
Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates.J Med Chem. 2010 Apr 22;53(8):3262-72. doi: 10.1021/jm901910j. J Med Chem. 2010. PMID: 20350006
-
Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery.Curr Opin Drug Discov Devel. 2007 Nov;10(6):756-67. Curr Opin Drug Discov Devel. 2007. PMID: 17987527 Review.
Cited by
-
Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.Eur J Pharm Sci. 2012 Feb 14;45(3):320-9. doi: 10.1016/j.ejps.2011.11.017. Epub 2011 Dec 3. Eur J Pharm Sci. 2012. PMID: 22155544 Free PMC article.
-
Cancer nanotechnology.Gastroenterol Hepatol Bed Bench. 2011 Spring;4(2):63-9. Gastroenterol Hepatol Bed Bench. 2011. PMID: 24834159 Free PMC article.
-
Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy.Theranostics. 2019 Oct 22;9(26):8362-8376. doi: 10.7150/thno.39816. eCollection 2019. Theranostics. 2019. PMID: 31754402 Free PMC article.
-
Design of multifunctional magnetic iron oxide nanoparticles/mitoxantrone-loaded liposomes for both magnetic resonance imaging and targeted cancer therapy.Int J Nanomedicine. 2014 Aug 22;9:4055-66. doi: 10.2147/IJN.S61880. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25187709 Free PMC article.
-
Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy.Pharm Res. 2014 Dec;31(12):3487-502. doi: 10.1007/s11095-014-1436-x. Epub 2014 Jun 13. Pharm Res. 2014. PMID: 24919932 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
